New treatments for prostate cancer, Multiple Sclerosis and cystic fibrosis could be developed following research being carried out into how medicinal ‘biologics’ can be delivered to diseased cells. Currently only 15 per cent of protein targets in human cancer cells can be ‘targeted therapeutically’, rendering the remaining 85 per cent of proteins out of reach…Continue Reading Tackling a large challenge for new modes of drug delivery